InsiderClue
← All stocks

Stoke Therapeutics, Inc.

STOK Net selling
CIK 0001623526 #2049 in the set updated 17 Sep 2026
Bought (120 mo)
$94.98M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$167.24M
$11.56M on a plan · $24.59M straight out of an exercise
Sold at will
$131.09M
77 of 244 sales
Net
−$72.26M
−$36.11M against sales at will

By person

17 insiders · 263 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Skorpios Trust entity
10% owner
—
$122.58M (4)
−$122.58M
3,906,181
6.05%
$121.31M
−73.0%
ATP Life Science Ventures, L.P. entity
10% owner
$39.63M (2)
—
+$39.63M
0
0.0000%
$0.00
—
Harrison Seth Loring
Director
$39.63M (2)
—
+$39.63M
33,948,426
52.61%
$1.05B
+102.2%
RTW INVESTMENTS, LP entity
10% owner
$15.73M (6)
$471.63K (1)
+$15.25M
3,544,248
5.49%
$110.07M
—
Nash Huw M.
Chief Business Officer
—
$12.24M (48) scheduled
−$12.24M
0
0.0000%
$0.00
−100.0%
Kaye Edward M. MD
Director
—
$8.45M (31) scheduled
−$8.45M
124,557
0.1930%
$3.87M
—
Ticho Barry
CHIEF MEDICAL OFFICER
—
$6.88M (75) scheduled
−$6.88M
20,110
0.0312%
$624.55K
+709.3%
Tulipano Stephen J
Former CFO
—
$4.52M (12) scheduled
−$4.52M
20,746
0.0322%
$644.31K
+3,346%
Krainer Adrian R.
Director
—
$3.90M (5) scheduled
−$3.90M
283,302
0.4390%
$8.80M
−30.0%
Allan Jonathan
GENERAL COUNSEL & CORP SEC
—
$2.82M (37) scheduled
−$2.82M
21,225
0.0329%
$659.18K
+114.7%
Liau Gene
EVP Research & Preclinical Dev
—
$2.60M (11) scheduled
−$2.60M
21,351
0.0331%
$663.10K
—
TZIANABOS ARTHUR
Director
—
$1.70M (6) scheduled
−$1.70M
31,339
0.0486%
$973.29K
—
LEVIN ARTHUR A
Director
—
$782.11K (3) scheduled
−$782.11K
22,216
0.0344%
$689.96K
+23.6%
Leggett Thomas
Chief Financial Officer
—
$147.14K (5)
−$147.14K
10,172
0.0158%
$315.91K
—
Hoitt Jason
Chief Patient Officer
—
$119.31K (5)
−$119.31K
10,276
0.0159%
$319.14K
+157.7%
Walker Robin A.
Chief Legal Officer, CCO & Sec
—
$21.17K (1)
−$21.17K
0
0.0000%
$0.00
−100.0%
Redmile Group, LLC entity
10% owner
—
—
—
671,808
1.04%
$20.86M
—

Individual transactions

94
Insider
Date
Role
Action
Shares
Price
Amount
Ticho Barry
19 Mar 2026
CHIEF MEDICAL OFFICER
Sold after exercise
1,461
$29.99
$43.82K
TZIANABOS ARTHUR
10 Mar 2026
Interim Executive Chair
Sold after exercise
4,355
$40.00
$174.21K
Kaye Edward M. MD
8 Oct 2025
Director
Sold after exercise
25,000
$30.00
$750.00K
Allan Jonathan
3 Oct 2025
GENERAL COUNSEL & CORP SEC
Sold after exercise
10,000
$25.07
$250.65K
Allan Jonathan
2 Sep 2025
GENERAL COUNSEL & CORP SEC
Sold after exercise
14,922
$20.14
$300.49K
Allan Jonathan
29 Aug 2025
GENERAL COUNSEL & CORP SEC
Sold after exercise
850
$20.00
$17.00K
Ticho Barry
2 Dec 2024
CHIEF MEDICAL OFFICER
Sold after exercise
10,000
$12.07
$120.70K
Ticho Barry
1 Nov 2024
CHIEF MEDICAL OFFICER
Sold after exercise
10,000
$12.68
$126.80K
Ticho Barry
1 Oct 2024
CHIEF MEDICAL OFFICER
Sold after exercise
10,000
$12.06
$120.65K
Ticho Barry
3 Sep 2024
CHIEF MEDICAL OFFICER
Sold after exercise
600
$15.41
$9.24K
Ticho Barry
3 Sep 2024
CHIEF MEDICAL OFFICER
Sold after exercise
9,400
$14.92
$140.24K
Ticho Barry
1 Aug 2024
CHIEF MEDICAL OFFICER
Sold after exercise
10,000
$14.58
$145.84K
Ticho Barry
1 Jul 2024
CHIEF MEDICAL OFFICER
Sold after exercise
10,000
$13.75
$137.46K
Ticho Barry
3 Jun 2024
CHIEF MEDICAL OFFICER
Sold after exercise
103
$15.78
$1.63K
Ticho Barry
3 Jun 2024
CHIEF MEDICAL OFFICER
Sold after exercise
9,897
$15.21
$150.56K
Allan Jonathan
20 May 2024
GENERAL COUNSEL & CORP SEC
Sold after exercise
8,599
$15.04
$129.33K
Nash Huw M.
20 May 2024
COO & CBO
Sold after exercise
50,000
$15.39
$769.50K
Ticho Barry
1 May 2024
CHIEF MEDICAL OFFICER
Sold after exercise
10,000
$11.37
$113.65K
Nash Huw M.
1 Apr 2024
COO & CBO
Sold after exercise
400
$13.61
$5.44K
Nash Huw M.
1 Apr 2024
COO & CBO
Sold after exercise
60,929
$13.22
$805.77K
Ticho Barry
1 Apr 2024
CHIEF MEDICAL OFFICER
Sold after exercise
9,426
$13.23
$124.68K
Ticho Barry
1 Mar 2024
CHIEF MEDICAL OFFICER
Sold after exercise
10,000
$7.75
$77.47K
Nash Huw M.
3 Jan 2022
COO & CBO
Sold after exercise
200
$24.07
$4.81K
Nash Huw M.
3 Jan 2022
COO & CBO
Sold after exercise
2,103
$23.40
$49.22K
Nash Huw M.
3 Jan 2022
COO & CBO
Sold after exercise
1,497
$22.47
$33.63K
Nash Huw M.
1 Dec 2021
COO & CBO
Sold after exercise
2,500
$25.06
$62.66K
Nash Huw M.
1 Dec 2021
COO & CBO
Sold after exercise
3,200
$23.96
$76.67K
Nash Huw M.
3 Nov 2021
COO & CBO
Sold after exercise
1,900
$25.00
$47.50K
Nash Huw M.
1 Nov 2021
COO & CBO
Sold after exercise
1,610
$23.72
$38.20K
Nash Huw M.
1 Nov 2021
COO & CBO
Sold after exercise
2,190
$23.41
$51.26K
Nash Huw M.
1 Oct 2021
COO & CBO
Sold after exercise
5,700
$24.83
$141.51K
Nash Huw M.
1 Sep 2021
COO & CBO
Sold after exercise
5,700
$26.00
$148.22K
Nash Huw M.
2 Aug 2021
COO & CBO
Sold after exercise
5,700
$28.87
$164.55K
Nash Huw M.
1 Jul 2021
COO & CBO
Sold after exercise
5,700
$33.33
$189.99K
Nash Huw M.
1 Jun 2021
COO & CBO
Sold after exercise
575
$39.43
$22.67K
Liau Gene
2 Mar 2021
EVP Research & Preclinical Dev
Sold after exercise
2,900
$63.52
$184.19K
Liau Gene
2 Mar 2021
EVP Research & Preclinical Dev
Sold after exercise
2,295
$62.46
$143.35K
LEVIN ARTHUR A
1 Mar 2021
Director
Sold after exercise
4,957
$61.14
$303.09K
LEVIN ARTHUR A
1 Mar 2021
Director
Sold after exercise
7,543
$60.55
$456.75K
Tulipano Stephen J
23 Feb 2021
CFO
Sold after exercise
5,000
$58.60
$292.99K
Tulipano Stephen J
22 Feb 2021
CFO
Sold after exercise
102
$60.00
$6.12K
Tulipano Stephen J
22 Feb 2021
CFO
Sold after exercise
9,696
$59.29
$574.84K
Tulipano Stephen J
22 Feb 2021
CFO
Sold after exercise
15,202
$58.67
$891.94K
TZIANABOS ARTHUR
19 Feb 2021
Director
Sold after exercise
10,000
$60.67
$606.65K
Nash Huw M.
4 Jan 2021
COO & CBO
Sold after exercise
200
$60.51
$12.10K
Nash Huw M.
4 Jan 2021
COO & CBO
Sold after exercise
1,800
$59.85
$107.72K
Nash Huw M.
4 Jan 2021
COO & CBO
Sold after exercise
2,200
$59.02
$129.84K
Nash Huw M.
4 Jan 2021
COO & CBO
Sold after exercise
1,500
$57.66
$86.49K
Liau Gene
28 Dec 2020
EVP Research & Preclinical Dev
Sold after exercise
149
$58.73
$8.75K
Ticho Barry
21 Dec 2020
Chief Medical Officer
Sold after exercise
365
$59.00
$21.53K
Ticho Barry
21 Dec 2020
Chief Medical Officer
Sold after exercise
286
$58.02
$16.59K
Ticho Barry
21 Dec 2020
Chief Medical Officer
Sold after exercise
714
$56.76
$40.53K
Nash Huw M.
18 Dec 2020
COO & CBO
Sold after exercise
8,015
$60.00
$480.90K
Nash Huw M.
17 Dec 2020
COO & CBO
Sold after exercise
41,985
$60.00
$2.52M
Nash Huw M.
1 Dec 2020
COO & CBO
Sold after exercise
400
$52.72
$21.09K
Nash Huw M.
1 Dec 2020
COO & CBO
Sold after exercise
100
$51.45
$5.15K
Nash Huw M.
1 Dec 2020
COO & CBO
Sold after exercise
2,481
$50.02
$124.10K
Nash Huw M.
1 Dec 2020
COO & CBO
Sold after exercise
2,719
$49.19
$133.74K
TZIANABOS ARTHUR
23 Nov 2020
Director
Sold after exercise
210
$47.61
$10.00K
TZIANABOS ARTHUR
23 Nov 2020
Director
Sold after exercise
5,294
$46.85
$248.01K
TZIANABOS ARTHUR
23 Nov 2020
Director
Sold after exercise
10,196
$45.97
$468.72K
TZIANABOS ARTHUR
23 Nov 2020
Director
Sold after exercise
4,300
$45.08
$193.84K
Nash Huw M.
10 Nov 2020
COO & CBO
Sold after exercise
50,000
$45.00
$2.25M
Tulipano Stephen J
4 Nov 2020
CFO
Sold after exercise
5,216
$41.97
$218.91K
Tulipano Stephen J
4 Nov 2020
CFO
Sold after exercise
11,111
$41.42
$460.21K
Tulipano Stephen J
4 Nov 2020
CFO
Sold after exercise
16,941
$40.03
$678.09K
Tulipano Stephen J
3 Nov 2020
CFO
Sold after exercise
1,732
$39.84
$69.00K
Nash Huw M.
2 Nov 2020
COO & CBO
Sold after exercise
2,536
$37.98
$96.32K
Nash Huw M.
2 Nov 2020
COO & CBO
Sold after exercise
3,164
$36.59
$115.78K
Tulipano Stephen J
2 Nov 2020
CFO
Sold after exercise
400
$38.44
$15.37K
Tulipano Stephen J
2 Nov 2020
CFO
Sold after exercise
14,445
$37.86
$546.91K
Tulipano Stephen J
2 Nov 2020
CFO
Sold after exercise
20,155
$36.79
$741.45K
Liau Gene
19 Oct 2020
EVP Research & Preclinical Dev
Sold after exercise
7,225
$38.42
$277.59K
Liau Gene
19 Oct 2020
EVP Research & Preclinical Dev
Sold after exercise
24,775
$37.64
$932.58K
Liau Gene
16 Oct 2020
EVP Research & Preclinical Dev
Sold after exercise
5,851
$40.00
$234.04K
Liau Gene
13 Oct 2020
EVP Research & Preclinical Dev
Sold after exercise
1,649
$40.00
$65.96K
Nash Huw M.
1 Oct 2020
COO & CBO
Sold after exercise
2,300
$34.86
$80.18K
Nash Huw M.
1 Oct 2020
COO & CBO
Sold after exercise
3,400
$34.33
$116.72K
Nash Huw M.
9 Sep 2020
COO & CBO
Sold after exercise
17,201
$30.00
$516.03K
Nash Huw M.
8 Sep 2020
COO & CBO
Sold after exercise
30,718
$30.00
$921.54K
Nash Huw M.
1 Sep 2020
COO & CBO
Sold after exercise
700
$28.71
$20.10K
Nash Huw M.
1 Sep 2020
COO & CBO
Sold after exercise
5,000
$27.60
$138.02K
Nash Huw M.
28 Aug 2020
COO & CBO
Sold after exercise
2,081
$30.00
$62.43K
Nash Huw M.
3 Aug 2020
COO & CBO
Sold after exercise
5,700
$24.73
$140.94K
Nash Huw M.
16 Jul 2020
COO & CBO
Sold after exercise
1,900
$25.06
$47.61K
Nash Huw M.
1 Jul 2020
COO & CBO
Sold after exercise
3,800
$23.15
$87.97K
Nash Huw M.
1 Jun 2020
COO & CBO
Sold after exercise
500
$27.48
$13.74K
Nash Huw M.
1 Jun 2020
COO & CBO
Sold after exercise
1,607
$27.08
$43.52K
Liau Gene
1 Jun 2020
EVP Research & Preclinical Dev
Sold after exercise
1,230
$27.48
$33.80K
Liau Gene
1 Jun 2020
EVP Research & Preclinical Dev
Sold after exercise
7,875
$26.91
$211.92K
Liau Gene
1 Jun 2020
EVP Research & Preclinical Dev
Sold after exercise
10,895
$25.82
$281.31K
Ticho Barry
1 Jun 2020
Chief Medical Officer
Sold after exercise
365
$27.98
$10.21K
Ticho Barry
1 Jun 2020
Chief Medical Officer
Sold after exercise
1,000
$27.17
$27.17K
Liau Gene
22 May 2020
EVP Research & Preclinical Dev
Sold after exercise
7,500
$30.00
$225.00K
Showing 250 of 263 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 272
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 13
Sales on a Rule 10b5-1 plan 71
Sales straight out of an exercise 96
Sales at will 77
Transactions with no price 0
Shares from compensation/vesting 53,171,597
Sales filed before the plan box existed 15
History held since 20 Jun 2019